Zynex Inc is a medical technology company that specializes in the development and manufacturing of non-invasive medical devices, primarily focused on pain management and rehabilitation
The company's innovative products include electrotherapy devices that utilize neuromuscular electrical stimulation to help patients manage acute and chronic pain, as well as devices designed to aid in physical therapy and recovery. Zynex is committed to improving patient outcomes through its advanced technology and is actively involved in expanding its offerings to meet the growing needs of the healthcare market.
Demand for pain management devices is climbing worldwide, fueled by several major trends. As chronic disease rates soar, the need for effective, drug-free pain solutions has grown more pressing. At the same time, advancements in medical tech have opened doors to safer, non-invasive pain relief options, making them more widely adopted by healthcare providers. Rising numbers of surgeries have also created a strong demand for post-operative pain control, while the pain monitoring market continues to surge. With these combined factors, the global pain management device market is expected to reach $5.68 billion by 2032, expanding at a steady 9% CAGR.
Explore our top picks for short-squeeze stocks that could skyrocket your portfolio. Learn what makes them stand out, and how to spot similar opportunities.
Zynex Inc's (NASDAQZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached.
